Companies: 10,795·Total market cap: $144.5T
Oculis Holding AG

Oculis Holding AG

OCSNASDAQHealthcare● Active
$10.71
$-0.50(-4.46%)
Market Cap$612285345
P/E Ratio—
52W High$34.475
52W Low$10.52
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Oculis Holding AG (OCS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001953530 · OCS · NASDAQ · as of Jun 8, 2026

Filing snapshot

131
Total Filings
6-K
Latest Form
2026-06-01
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001953530 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-04
Fiscal Year End
Mar 4, 2026
Accession No.
0001193125-26-091446
Primary Document
ocs-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001953530 · Accession 0001193125-26-091446

Latest Key Filings

6-KQuarterly Report
6-K
2026-06-01
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-14
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-11
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-04-29
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-21
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-27
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-04
View
F-3ASRF-3ASR
F-3ASR
2026-03-04
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-03-04
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-03
View
EFFECTEFFECT
EFFECT
2025-12-08
View
POS AMPOS AM
POS AM
2025-12-05
View
424B3424B3
424B3
2025-12-01
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-11-14
View
F-3F-3
F-3
2025-11-10
View
Showing 1–15 of 127 filingsForm 4 / 144 hidden· 131 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001953530  |  Exchange: NASDAQ · Healthcare

Oculis Holding AG (NASDAQ: OCS) has submitted 131 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001953530, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Oculis Holding AG's most comprehensive regulatory disclosure. The most recent Oculis Holding AG 10-K was filed on 2026-03-04 for fiscal year ending 2026. Historical OCS 10-K annual reports are available from 2022 through 2026.

Investors researching Oculis Holding AG SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ANAB SEC Filings →KOD SEC Filings →MNMD SEC Filings →NRIX SEC Filings →URGN SEC Filings →NKTR SEC Filings →XNCR SEC Filings →PHAT SEC Filings →
→ OCS Financials→ OCS Earnings→ OCS Insider Trades

Frequently Asked Questions

OCS SEC Filings · 8 questions

Oculis Holding AG (OCS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 131 filings and access original documents at no cost. Oculis Holding AG's CIK is 0001953530.

OCS SEC filingsOculis Holding AG SEC documentsfind OCS 10-K